Search

everythinglearnresearchcommunity

for

Search:↓

PDGFA/AKT signaling is important for the growth and maintenance of certain skin fat cells.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Hair's strength and flexibility come from its protein structure and molecular interactions.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Zinc levels and lymphocyte counts might be important in heart disease development.

Exosomes from skin cells can boost hair growth by stimulating a gene called LEF1.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Different proteins are linked to the varying thickness of sheep and goat hair types.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.